Kamada (KMDA) Depreciation and Depletion (2017 - 2026)
Kamada's (KMDA) quarterly Depreciation and Depletion came in at $3.8 million in Q3 2025, up 15.98% YoY from $3.2 million in Q3 2024, and little changed on a QoQ basis from $3.7 million in Q2 2025.
Kamada (KMDA) Depreciation and Depletion (2017 - 2026) Analysis & Trends
Kamada (KMDA) has 9 years of Depreciation and Depletion data on file, last reported at $3.8 million in Q3 2025.
- Quarterly Depreciation and Depletion rose 15.98% year-over-year to $3.8 million in Q3 2025, while the trailing twelve-month figure through Sep 2025 was $14.8 million (up 53.81% YoY) and the FY2024 annual result came in at $13.8 million, up 8.6% from the prior year.
- Depreciation and Depletion was little changed at $3.8 million in Q3 2025, from $3.7 million in the prior quarter.
- In the past five years, Depreciation and Depletion ranged from a high of $4.1 million in Q4 2024 to a low of $1997.0 in Q4 2021.
- A 5-year average of $2.2 million and a median of $3.1 million in 2022 frame the typical range for Depreciation and Depletion.
- Annual changes were most pronounced in 2021 — Depreciation and Depletion tumbled 99.84% — and 2024, when it soared 127705.49%.
- Tracing KMDA's Depreciation and Depletion over 5 years: stood at $1997.0 in 2021, then surged by 50.83% to $3012.0 in 2022, then rose by 6.51% to $3208.0 in 2023, then soared by 127705.49% to $4.1 million in 2024, then decreased by 8.29% to $3.8 million in 2025.
- The last three Depreciation and Depletion figures came in at $3.8 million (Q3 2025), $3.7 million (Q2 2025), and $4.1 million (Q4 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation and Depletion (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.28 Bn | 39.62 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.78 Bn | 30.11 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.71 Bn | 22.91 Bn | 5.10 Bn | - |
| 5 | United Therapeutics | 22.25 Bn | 19.59 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.72 Bn | 17.83 Bn | 1.46 Bn | - |
| 7 | Neurocrine Biosciences | 15.57 Bn | 15.18 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.97 Bn | - | - |
| 10 | Kamada | 464.05 Mn | 434.58 Mn | 22.47 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.56 Mn |
| Mar 31, 2026 | 1.56 Mn |
| Dec 31, 2025 | -8.35 Mn |
| Dec 31, 2025 | -8.35 Mn |
| Sep 30, 2025 | 3.76 Mn |
| Sep 30, 2025 | 3.76 Mn |
| Jun 30, 2025 | 3.75 Mn |
| Jun 30, 2025 | 3.75 Mn |
| Dec 31, 2024 | 4.10 Mn |
| Dec 31, 2024 | 4.10 Mn |
| Sep 30, 2024 | 3.24 Mn |
| Sep 30, 2024 | 3.24 Mn |
| Jun 30, 2024 | 3.23 Mn |
| Jun 30, 2024 | 3.23 Mn |
| Dec 31, 2023 | 3,208.00 |
| Dec 31, 2023 | 3,208.00 |
| Sep 30, 2023 | 3.18 Mn |
| Sep 30, 2023 | 3.18 Mn |
| Jun 30, 2023 | 3.20 Mn |
| Jun 30, 2023 | 3.20 Mn |